Page 15 - Financial Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the pricing of its previously announced global follow-on offering reserved to specified categories of investors, consisting of (i) an offering of 3,106,907 American Depositary Shares (“ADSs”), each representing o

PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer,...

PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer,...

CONTENTS APPENDIX Cross-reference table of the management report of the Board of Directors ...

CONDITIONS D'UTILISATION DU FORMULAIRE GENERALITES : Il s'agit d'un formulaire unique prévu par l'article R. 225-76 du...